Prenuvo, a healthcare startup backed by Spotify co-founders and other investors, is accelerating its business expansion in the US market. The company offers preventive healthcare services that enable early disease detection using proprietary full-body scanning technology.
At the core of Prenuvo's offering is a technology that performs full-body MRI scans while minimizing radiation exposure. This service aims to identify conditions such as cancers and aneurysms even before symptoms appear, providing a new option for preventive medicine. Its technical advantages lie in its ability to cover the entire body in high resolution with significantly shorter scan times compared to conventional MRI diagnostics.
With its full-scale entry into the US market, Prenuvo is actively expanding its scanning locations across major American cities. Rather than merely offering diagnostic services, the company aims to integrate accumulated data and technology to gain a more detailed understanding of individual health conditions, evolving into a personalized health management platform.